Substance Abuse and Movement Disorders

被引:31
|
作者
Brust, John C. M. [1 ,2 ]
机构
[1] Harlem Hosp Med Ctr, Dept Neurol, New York, NY 10037 USA
[2] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
关键词
ethanol; heroin; meperidine; psychostimulant; myoclonus; GAMMA-HYDROXYBUTYRIC ACID; OBSESSIVE-COMPULSIVE DISORDER; PARKINSONS-DISEASE; ALCOHOL-WITHDRAWAL; MULTIPLE-SCLEROSIS; MYOCLONUS-DYSTONIA; TOURETTES-SYNDROME; CIGARETTE-SMOKING; ESSENTIAL TREMOR; CHOREOATHETOID MOVEMENTS;
D O I
10.1002/mds.22599
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus-dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders. (C) 2010 Movement Disorder Society
引用
收藏
页码:2010 / 2020
页数:11
相关论文
共 50 条
  • [1] Movement disorders and substance abuse
    Lopez, W
    Jeste, DV
    [J]. PSYCHIATRIC SERVICES, 1997, 48 (05) : 634 - 636
  • [2] Movement disorders in patients with schizophrenia and a history of substance abuse
    Hansen, Lars K.
    Nausheen, Bina
    Hart, Deborah
    Kingdon, David
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (02) : 192 - 197
  • [3] Neuroimaging in substance abuse disorders
    de Mendelssohn, A
    Kasper, S
    Tauscher, J
    [J]. NERVENARZT, 2004, 75 (07): : 651 - +
  • [4] Bipolar disorders and substance abuse
    Aubin, H. -J.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2006, 32 : 25 - 29
  • [5] Anxiety disorders and substance abuse
    Prieto Sanchez, I.
    Ramirez Dominguez, M. D. L. C.
    Fernandez Leon, S.
    Reina Dominguez, M.
    Garrido Torres, N.
    Rodriguez Martinez, A.
    Biedma Martin, A. S.
    Gonzalez Macias, C.
    [J]. EUROPEAN PSYCHIATRY, 2016, 33 : S384 - S384
  • [6] Personality disorders and substance abuse
    Ristic-Ilic, J.
    [J]. HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2018, 20 : 24 - 24
  • [7] MOVEMENT DISORDERS AND MDMA ABUSE
    Wilcox, James Allen
    Wilcox, Aidee Herrera
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 2009, 41 (02) : 203 - 204
  • [8] Psychotic disorders and substance abuse in adolescents
    Fleischhaker, C
    Priemer, K
    Schulz, E
    Remschmidt, H
    [J]. ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2002, 30 (02): : 87 - 95
  • [9] Adolescent substance abuse and internalizing disorders
    Clark, DB
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 1996, 5 (01) : 45 - &
  • [10] Family therapy in substance abuse disorders
    Bressi, C
    Invernizzi, G
    [J]. EUROPEAN PSYCHIATRY, 2000, 15 : 429S - 429S